Investor Stock List
Ranked #2,922 of 8,699 institutional investors

First Turn Management, LLC

Del Mar, CA

$718M
US stock portfolio at live prices · today +$8.2M (+1.15%)
Market closed. Prices as of Nov 20, 6:41 AM ET
Value at quarter end (Q3 2026)
$753M
Change from Q2 2026
−$181.7M (−19.44%)
Positions
34 · 13 new, 4 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$76.8M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
VRDN 6.68%ELVN 6.19%INSM 4.94%UTHR 4.68%GH 4.45%
StockSharesValue, live% of portfoliovs Q2 2026
VRDN Viridian Therapeutics, Inc.1,525,220$48.0M6.68%Reduced −9%
ELVN Enliven Therapeutics, Inc.958,700$44.5M6.19%Added +0%
INSM Insmed Incorporated245,726$35.5M4.94%Reduced −7%
UTHR United Therapeutics Corporation60,064$33.6M4.68%Reduced −29%
GH Guardant Health, Inc.219,304$31.9M4.45%New
ABVX ABIVAX Société Anonyme384,592$31.0M4.32%Reduced −21%
CRL Charles River Laboratories International, Inc.86,801$28.5M3.96%New
BBIO BridgeBio Pharma, Inc.354,371$27.7M3.86%Reduced −44%
PRAX Praxis Precision Medicines, Inc.78,806$24.5M3.41%Reduced −6%
AXSM Axsome Therapeutics, Inc.162,407$22.0M3.07%Reduced −26%
CELC Celcuity Inc.329,101$18.5M2.58%Unchanged
RGEN Repligen Corporation108,436$18.5M2.57%New
CYTK Cytokinetics, Incorporated357,945$18.4M2.56%Reduced −32%
RYTM Rhythm Pharmaceuticals, Inc.157,603$18.4M2.56%Added +2%
TNGX Tango Therapeutics, Inc.766,860$17.4M2.42%New
MANE Veradermics Inc136,718$17.0M2.37%New
IRON Disc Medicine, Inc.220,666$16.8M2.34%New
PVLA Palvella Therapeutics, Inc.109,871$16.0M2.23%Reduced −30%
DNTH Dianthus Therapeutics, Inc.178,573$15.1M2.11%Reduced −38%
RVMD Revolution Medicines, Inc.92,316$14.7M2.05%Reduced −78%
COGT Cogent Biosciences, Inc.514,976$14.3M1.99%Reduced −14%
KYMR Kymera Therapeutics, Inc.113,299$13.5M1.88%Added +11%
ERAS Erasca, Inc.913,452$13.0M1.81%Reduced −25%
INBX Inhibrx Biosciences, Inc.171,512$12.7M1.77%Added +4%
ORIC ORIC Pharmaceuticals, Inc.1,574,334$12.1M1.69%Reduced −22%
XENE Xenon Pharmaceuticals Inc.297,060$11.2M1.55%Reduced −51%
SYRE Spyre Therapeutics, Inc.102,541$10.0M1.39%New
GRAL GRAIL, Inc.93,727$9.8M1.37%New
ARWR Arrowhead Pharmaceuticals, Inc.222,649$9.7M1.35%New
RCUS Arcus Biosciences, Inc.577,693$9.1M1.27%New
HNGE Hinge Health, Inc.75,448$8.2M1.14%New
PCVX Vaxcyte, Inc.137,534$8.0M1.12%Reduced −69%
DFTX Definium Therapeutics, Inc.216,531$6.4M0.89%New
SMMT Summit Therapeutics Inc.501,724$5.3M0.74%New

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
MIRM Mirum Pharmaceuticals, Inc.218,051$20.8M
ORKA Oruka Therapeutics, Inc.155,343$15.2M
SRRK Scholar Rock Holding Corporation271,227$13.7M
SION Sionna Therapeutics, Inc.110,493$328K